Literature DB >> 17516488

Pathophysiological concepts of restless legs syndrome.

Walter Paulus1, Pascal Dowling1, Roselyne Rijsman2, Karin Stiasny-Kolster3, Claudia Trenkwalder4, Al de Weerd5.   

Abstract

Pathophysiological concepts of restless legs syndrome (RLS) are based mainly on neuroimaging and on neurophysiological data. Furthermore treatment effects contribute essentially to the present understanding of the disease, unless the genetic progress expected in the near future will clarify substantially open issues. The concept agreed on assumes a dysfunction of the dopaminergic system, possibly on the level of striatal and/or spinal dopamine receptors, and the A11 neuron group localized in the hypothalamus as an integrated part of the system. These neurons modulate spinal excitability, alterations of which in turn affect sensory processing predominantly of leg afferents in brain stem structures. Neurophysiologically excitability alterations can be measured by a variety of methods such as determination of pain thresholds, H-reflex testing, and quantitative sensory testing. Copyright 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516488     DOI: 10.1002/mds.21533

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  Vascular risk factors, cardiovascular disease, and restless legs syndrome in women.

Authors:  Anke C Winter; Markus Schürks; Robert J Glynn; Julie E Buring; J Michael Gaziano; Klaus Berger; Tobias Kurth
Journal:  Am J Med       Date:  2013-03       Impact factor: 4.965

2.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

Review 3.  Sensory aspects of movement disorders.

Authors:  Neepa Patel; Joseph Jankovic; Mark Hallett
Journal:  Lancet Neurol       Date:  2014-01       Impact factor: 44.182

4.  Migraine and restless legs syndrome in women.

Authors:  Markus Schürks; Anke C Winter; Klaus Berger; Julie E Buring; Tobias Kurth
Journal:  Cephalalgia       Date:  2012-03-06       Impact factor: 6.292

5.  The conserved dopaminergic diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae.

Authors:  Aaron M Lambert; Joshua L Bonkowsky; Mark A Masino
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

Review 6.  Rotigotine transdermal patch: in restless legs syndrome.

Authors:  Claudine M Baldwin; Gillian M Keating
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Prospective study of restless legs syndrome and risk of erectile dysfunction.

Authors:  Yanping Li; Salma Batool-Anwar; Sehee Kim; Eric B Rimm; Alberto Ascherio; Xiang Gao
Journal:  Am J Epidemiol       Date:  2013-04-21       Impact factor: 4.897

8.  Refractory restless legs syndrome likely caused by olanzapine.

Authors:  Imran Khalid; Lopa Rana; Tabindeh J Khalid; Timothy Roehrs
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

9.  The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li
Journal:  Exp Neurol       Date:  2019-11-09       Impact factor: 5.330

10.  Evaluation of Optical Coherence Tomography Results and Cognitive Functions in Patients with Restless Legs Syndrome.

Authors:  Ali Zeynal Abidin Tak; Mustafa Çelİk; Aysun Kalenderoğlu; Sadullah Sağlam; Yaşar Altun; Emre Gedİk
Journal:  Noro Psikiyatr Ars       Date:  2018-07-12       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.